Indication:

IracetTM (Levetiracetam) is indicated as an adjunctive therapy for Partial Onset Seizures, Myoclonic Seizures in Patients with Juvenile Myoclonic Epilepsy, Primary Generalized Tonic-Clonic Seizures

Dosage & Administration:

Treatment should be initiated with a daily dose of 1000 mg/day, given as twice-daily dosing (500 mg twice daily). Additional dosing increments may be given (1000 mg/day additional every 2 weeks) to a maximum recommended daily dose of 3000 mg.

Use in Pediatric Patients